108 related articles for article (PubMed ID: 31014671)
1. ALOX12 inhibition sensitizes breast cancer to chemotherapy via AMPK activation and inhibition of lipid synthesis.
Huang Z; Xia L; Zhou X; Wei C; Mo Q
Biochem Biophys Res Commun; 2019 Jun; 514(1):24-30. PubMed ID: 31014671
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of arachidonate lipoxygenase12 targets lung cancer through inhibiting EMT and suppressing RhoA and NF-κB activity.
Chen J; Tong W; Liao M; Chen D
Biochem Biophys Res Commun; 2020 Apr; 524(4):803-809. PubMed ID: 32037090
[TBL] [Abstract][Full Text] [Related]
3. AMPK inhibits MTDH expression via GSK3β and SIRT1 activation: potential role in triple negative breast cancer cell proliferation.
Gollavilli PN; Kanugula AK; Koyyada R; Karnewar S; Neeli PK; Kotamraju S
FEBS J; 2015 Oct; 282(20):3971-85. PubMed ID: 26236947
[TBL] [Abstract][Full Text] [Related]
4. 6PGD inhibition sensitizes hepatocellular carcinoma to chemotherapy via AMPK activation and metabolic reprogramming.
Chen H; Wu D; Bao L; Yin T; Lei D; Yu J; Tong X
Biomed Pharmacother; 2019 Mar; 111():1353-1358. PubMed ID: 30841449
[TBL] [Abstract][Full Text] [Related]
5. Inhibiting 6-phosphogluconate dehydrogenase selectively targets breast cancer through AMPK activation.
Yang X; Peng X; Huang J
Clin Transl Oncol; 2018 Sep; 20(9):1145-1152. PubMed ID: 29340974
[TBL] [Abstract][Full Text] [Related]
6. Anticancer properties of pomolic acid-induced AMP-activated protein kinase activation in MCF7 human breast cancer cells.
Youn SH; Lee JS; Lee MS; Cha EY; Thuong PT; Kim JR; Chang ES
Biol Pharm Bull; 2012; 35(1):105-10. PubMed ID: 22223345
[TBL] [Abstract][Full Text] [Related]
7. β-Glucosidase inhibition sensitizes breast cancer to chemotherapy.
Zhou X; Huang Z; Yang H; Jiang Y; Wei W; Li Q; Mo Q; Liu J
Biomed Pharmacother; 2017 Jul; 91():504-509. PubMed ID: 28478274
[TBL] [Abstract][Full Text] [Related]
8. 6PGD Upregulation is Associated with Chemo- and Immuno-Resistance of Renal Cell Carcinoma via AMPK Signaling-Dependent NADPH-Mediated Metabolic Reprograming.
Cao J; Sun X; Zhang X; Chen D
Am J Med Sci; 2020 Sep; 360(3):279-286. PubMed ID: 32829780
[TBL] [Abstract][Full Text] [Related]
9. AMPK activators suppress breast cancer cell growth by inhibiting DVL3-facilitated Wnt/β-catenin signaling pathway activity.
Zou YF; Xie CW; Yang SX; Xiong JP
Mol Med Rep; 2017 Feb; 15(2):899-907. PubMed ID: 28035400
[TBL] [Abstract][Full Text] [Related]
10. Ischemia reperfusion injury promotes recurrence of hepatocellular carcinoma in fatty liver via ALOX12-12HETE-GPR31 signaling axis.
Yang F; Zhang Y; Ren H; Wang J; Shang L; Liu Y; Zhu W; Shi X
J Exp Clin Cancer Res; 2019 Dec; 38(1):489. PubMed ID: 31831037
[TBL] [Abstract][Full Text] [Related]
11. ADIPOQ/adiponectin induces cytotoxic autophagy in breast cancer cells through STK11/LKB1-mediated activation of the AMPK-ULK1 axis.
Chung SJ; Nagaraju GP; Nagalingam A; Muniraj N; Kuppusamy P; Walker A; Woo J; Győrffy B; Gabrielson E; Saxena NK; Sharma D
Autophagy; 2017 Aug; 13(8):1386-1403. PubMed ID: 28696138
[TBL] [Abstract][Full Text] [Related]
12. Acetyl-CoA carboxylase rewires cancer metabolism to allow cancer cells to survive inhibition of the Warburg effect by cetuximab.
Luo J; Hong Y; Lu Y; Qiu S; Chaganty BK; Zhang L; Wang X; Li Q; Fan Z
Cancer Lett; 2017 Jan; 384():39-49. PubMed ID: 27693630
[TBL] [Abstract][Full Text] [Related]
13. TRPV1 Hyperfunction Involved in Uremic Toxin Indoxyl Sulfate-Mediated Renal Tubular Damage.
Lu CL; Liao CH; Lu KC; Ma MC
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32867359
[TBL] [Abstract][Full Text] [Related]
14. Molecular mechanism of suppression of MDR1 by puerarin from Pueraria lobata via NF-kappaB pathway and cAMP-responsive element transcriptional activity-dependent up-regulation of AMP-activated protein kinase in breast cancer MCF-7/adr cells.
Hien TT; Kim HG; Han EH; Kang KW; Jeong HG
Mol Nutr Food Res; 2010 Jul; 54(7):918-28. PubMed ID: 20077420
[TBL] [Abstract][Full Text] [Related]
15. Induction of AMPK activation by N,N'-diarylurea FND-4b decreases growth and increases apoptosis in triple negative and estrogen-receptor positive breast cancers.
Johnson J; Rychahou P; Sviripa VM; Weiss HL; Liu C; Watt DS; Evers BM
PLoS One; 2019; 14(3):e0209392. PubMed ID: 30875375
[TBL] [Abstract][Full Text] [Related]
16. AMP-activated kinase (AMPK) regulates activity of HER2 and EGFR in breast cancer.
Jhaveri TZ; Woo J; Shang X; Park BH; Gabrielson E
Oncotarget; 2015 Jun; 6(17):14754-65. PubMed ID: 26143491
[TBL] [Abstract][Full Text] [Related]
17. ALOX12 in human toxoplasmosis.
Witola WH; Liu SR; Montpetit A; Welti R; Hypolite M; Roth M; Zhou Y; Mui E; Cesbron-Delauw MF; Fournie GJ; Cavailles P; Bisanz C; Boyer K; Withers S; Noble AG; Swisher CN; Heydemann PT; Rabiah P; Muench SP; McLeod R
Infect Immun; 2014 Jul; 82(7):2670-9. PubMed ID: 24686056
[TBL] [Abstract][Full Text] [Related]
18. PIK3CA mutation sensitizes breast cancer cells to synergistic therapy of PI3K inhibition and AMPK activation.
Liu S; Tang Y; Yan M; Jiang W
Invest New Drugs; 2018 Oct; 36(5):763-772. PubMed ID: 29504069
[TBL] [Abstract][Full Text] [Related]
19. Proteasome inhibitors induce AMPK activation via CaMKKβ in human breast cancer cells.
Deshmukh RR; Dou QP
Breast Cancer Res Treat; 2015 Aug; 153(1):79-88. PubMed ID: 26227473
[TBL] [Abstract][Full Text] [Related]
20. Hypoxic preconditioning protects rat hearts against ischemia-reperfusion injury via the arachidonate12-lipoxygenase/transient receptor potential vanilloid 1 pathway.
Lu MJ; Chen YS; Huang HS; Ma MC
Basic Res Cardiol; 2014 Jul; 109(4):414. PubMed ID: 24816396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
